Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans
Eugenii A. Rabiner,John D. Beaver,Aidan Makwana,Graham E. Searle,Christopher J. Long,Pradeep J. Nathan,Rexford D. Newbould,J. Howard,Sam R. Miller,Mark A. Bush,S. Hill,Richard R. Reiley,Jan Passchier,Roger N. Gunn,Roger N. Gunn,Phillippa Matthews,Edward T. Bullmore +16 more
Reads0
Chats0
TLDR
It is shown how the pharmacological properties of OR antagonists can be characterised directly in humans by a novel integration of molecular and functional neuroimaging techniques.Abstract:
Opioid neurotransmission has a key role in mediating reward-related behaviours. Opioid receptor (OR) antagonists, such as naltrexone (NTX), can attenuate the behaviour-reinforcing effects of primary (food) and secondary rewards. GSK1521498 is a novel OR ligand, which behaves as an inverse agonist at the μ-OR sub-type. In a sample of healthy volunteers, we used [11C]-carfentanil positron emission tomography to measure the OR occupancy and functional magnetic resonance imaging (fMRI) to measure activation of brain reward centres by palatable food stimuli before and after single oral doses of GSK1521498 (range, 0.4–100 mg) or NTX (range, 2–50 mg). GSK1521498 had high affinity for human brain ORs (GSK1521498 effective concentration 50=7.10 ng ml−1) and there was a direct relationship between receptor occupancy (RO) and plasma concentrations of GSK1521498. However, for both NTX and its principal active metabolite in humans, 6-β-NTX, this relationship was indirect. GSK1521498, but not NTX, significantly attenuated the fMRI activation of the amygdala by a palatable food stimulus. We thus have shown how the pharmacological properties of OR antagonists can be characterised directly in humans by a novel integration of molecular and functional neuroimaging techniques. GSK1521498 was differentiated from NTX in terms of its pharmacokinetics, target affinity, plasma concentration–RO relationships and pharmacodynamic effects on food reward processing in the brain. Pharmacological differentiation of these molecules suggests that they may have different therapeutic profiles for treatment of overeating and other disorders of compulsive consumption.read more
Citations
More filters
Journal ArticleDOI
The Neurobiological Underpinnings of Obesity and Binge Eating: A Rationale for Adopting the Food Addiction Model
Dana G. Smith,Trevor W. Robbins +1 more
TL;DR: Critically examine common and divergent characteristics using the theoretical framework of prominent drug addiction models, investigating the neurobiological underpinnings of both behaviors in an attempt to justify whether classification of obesity and binge eating as an addictive disorder is merited.
Journal ArticleDOI
Positron emission tomography molecular imaging for drug development.
Paul M. Matthews,Paul M. Matthews,Eugenii A. Rabiner,Eugenii A. Rabiner,Jan Passchier,Roger N. Gunn,Roger N. Gunn,Roger N. Gunn +7 more
TL;DR: The potential value of a translational molecular imaging strategy should be considered routinely and at the earliest stages of new drug development to increase returns on R and D investment and reduce new drug attrition in later stages.
Journal ArticleDOI
Multimodal General Anesthesia: Theory and Practice
TL;DR: In this article, a rational strategy for multimodal general anesthesia is proposed, which is based on choosing a combination of agents that act at different targets in the nociceptive system to control intra-operative and post-operative pain.
Journal ArticleDOI
The contribution of brain reward circuits to the obesity epidemic
TL;DR: It is suggested that it might be more useful to focus on overeating that results in frank obesity, and multiple health, interpersonal, and occupational negative consequences as a form of food "abuse".
Journal ArticleDOI
Basolateral Amygdala Response to Food Cues in the Absence of Hunger Is Associated with Weight Gain Susceptibility
Xue Sun,Nils B. Kroemer,Maria G. Veldhuizen,Amanda E. Babbs,Ivan E. de Araujo,Darren R. Gitelman,Robert S. Sherwin,Rajita Sinha,Dana M. Small +8 more
TL;DR: It is demonstrated here that the amygdala response to the taste of a milkshake when sated but not hungry positively predicts weight change, and this finding suggests that, as in rodents, external cues gain access to the homeostatic control circuits of the human hypothalamus via the amygdala.
References
More filters
Journal ArticleDOI
Factor structure of the Barratt impulsiveness scale.
TL;DR: The results of the present study suggest that the total score of the BIS-11 is an internally consistent measure of impulsiveness and has potential clinical utility for measuring impulsiveness among selected patient and inmate populations.
Journal ArticleDOI
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.
Clifford R. Jack,Matt A. Bernstein,Nick C. Fox,Paul M. Thompson,Gene E. Alexander,Danielle J Harvey,Bret J. Borowski,Paula J. Britson,Jennifer L. Whitwell,Chadwick P. Ward,Anders M. Dale,Joel P. Felmlee,Jeffrey L. Gunter,Derek L. G. Hill,Ronald J. Killiany,Norbert Schuff,Sabrina Fox-Bosetti,Chen Lin,Colin Studholme,Charles DeCarli,Gunnar Krueger,Heidi A. Ward,Gregory J. Metzger,Katherine T. Scott,Richard Philip Mallozzi,Daniel J. Blezek,Joshua Levy,Josef Phillip Debbins,Adam S. Fleisher,Marilyn S. Albert,Robert C. Green,George Bartzokis,Gary H. Glover,John P. Mugler,Michael W. Weiner +34 more
TL;DR: The approach taken in ADNI to standardization across sites and platforms of the MRI protocol, postacquisition corrections, and phantom‐based monitoring of all scanners could be used as a model for other multisite trials.
Journal ArticleDOI
Endogenous opioid peptides: multiple agonists and receptors
TL;DR: It is concluded that the opioid peptidergic system has agonists of different characteristics which interact with more than one type of receptor.
Journal ArticleDOI
Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex
TL;DR: The basolateral amygdala (BLA) appears to be required for a Pavlovian conditioned stimulus to gain access to the current value of the specific unconditioned stimulus (US) that it predicts, while the central nucleus of the amygdala acts as a controller of brainstem arousal and response systems, and subserves some forms of stimulus-response Pavlovia conditioning.
Journal ArticleDOI
Consensus nomenclature for in vivo imaging of reversibly binding radioligands
Robert B. Innis,Vincent J. Cunningham,Jacques Delforge,Masahiro Fujita,Albert Gjedde,Roger N. Gunn,James E. Holden,Sylvain Houle,Sung-Cheng Huang,Masanori Ichise,Hidehiro Iida,Hiroshi Ito,Yuichi Kimura,Robert A. Koeppe,Gitte M. Knudsen,Juhani Knuuti,Adriaan A. Lammertsma,Marc Laruelle,Jean Logan,Ralph Paul Maguire,Mark A. Mintun,Evan D. Morris,Ramin V. Parsey,Julie C. Price,Mark Slifstein,Vesna Sossi,Tetsuya Suhara,John R. Votaw,Dean F. Wong,Richard E. Carson +29 more
TL;DR: An international group of experts in pharmacokinetic modeling recommends a consensus nomenclature to describe in vivo molecular imaging of reversibly binding radioligands.